Consultations
Search open and closed consultations on the way we regulate medicines, medical devices and biologicals.
- You can also find, read and respond to recent consultations, submissions and decisions at the TGA Consultation hub.
- Find more scheduling consultations on the Poisons Standard in our Interim decisions.
- Archived consultations and reviews can be viewed on the National Library of Australia Trove site.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Scheduling (national classification system) (83)
- Legislation (16)
- Committees and advisory bodies (12)
- Labelling and packaging (9)
- Manufacturing (9)
- Safety monitoring and information (6)
- Fees and payments (5)
- Advertising (4)
- Sunscreens (4)
- Import and export (3)
- Shortages and supply disruptions (3)
- Compliance and enforcement (2)
- Medicinal cannabis hub (2)
- Clinical trials (1)
- Unique Device Identification (UDI) hub (1)
- Vaping hub (1)
Use the filters or search function to help find relevant consultations.
Search
281 result(s) found, displaying 101 to 125
-
ConsultationThe TGA is seeking feedback on a proposed priority pathway for assessment of certain novel and life-saving biologicals. Closing date: 28 March 2022
-
ConsultationThe TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on options for the TGA's proposed fees and charges for the 2022-23 financial year. Closing date: 7 March 2022
-
ConsultationThe TGA is seeking feedback on whether certain international scientific guidelines should be adopted. Closing date: 20 February 2022
-
ConsultationThe TGA is seeking feedback from sponsors on improving their access to medicine adverse event data. Closing date 18 February 2022
-
ConsultationThe TGA is seeking feedback on a proposal to improve patient access to critical medicines in acute-care settings. Closing date: 7 February 2022
-
ConsultationProposed amendments to the Poisons Standard. Closing date: 31 January 2022
-
ConsultationThe TGA is conducting a public consultation on potential options for the regulation of biologicals manufactured in Australia for export only (and not for supply in Australia). Closing date: 20 December 2021
-
ConsultationThe TGA sought feedback on a Discussion paper on potential changes to mandatory reporting of medical device adverse events.
-
ConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 23 June 2021 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
ConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 23 June 2021 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
ConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 23-24 June 2021 meeting of the Advisory Committee on Medicines Scheduling (ACMS).
-
ConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 23-24 June 2021 meeting of the Advisory Committee on Medicines Scheduling (ACMS).
-
ConsultationThe consultation period on changes to the assistive technologies exemption has been extended to 22 October 2021.
-
ConsultationProposed amendments to the Poisons Standard. Closing date: 7 October 2021
-
ConsultationOutcomes of the consultation and submissions received have now been published
-
Consultation: Proposed changes to Required Advisory Statements for Medicine Labels (RASML): Triptans
ConsultationOutcomes of the consultation and submissions received have now been published -
ConsultationOutcomes of the consultation and submissions received have now been published
-
ConsultationOutcomes of the consultation and submissions received have now been published
-
ConsultationThe outcome of the Listed medicines ingredient low-negligible risk changes 2021-22 have been published
-
ConsultationThe public consultation for the Proposed refinements to the requirements for medical device patient information materials.
-
ConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 17-18 March 2021 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and Advisory Committee on Chemicals Scheduling (ACCS).
-
ConsultationSubmissions published and summarised as part of a consultation on medical devices that are substances for introduction into the body.
-
ConsultationThe closing date has been extended and now closes on 14 July
-
ConsultationThe TGA is seeking feedback on a proposal to remake some of the legislative instruments relating to human cell and tissue (HCT) products (including blood and blood components), which sunset in October 2021. Closing date: 11 July 2021
-
ConsultationThe outcomes of the public consultation into proposed improvements to the Therapeutic Goods Advertising Code have been published.